272 related articles for article (PubMed ID: 33023246)
1. The Progression of Hemophilic Arthropathy: The Role of Biomarkers.
Pasta G; Annunziata S; Polizzi A; Caliogna L; Jannelli E; Minen A; Mosconi M; Benazzo F; Di Minno MND
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023246
[TBL] [Abstract][Full Text] [Related]
2. Altered collagen turnover in factor VIII-deficient rats with hemophilic arthropathy identifies potential novel serological biomarkers in hemophilia.
Manon-Jensen T; Karsdal MA; Nielsen LN; Kjelgaard-Hansen M; Vandahl B; Olsen EH; Enoksson M; Roepstorff K
J Thromb Haemost; 2016 Dec; 14(12):2419-2429. PubMed ID: 27681457
[TBL] [Abstract][Full Text] [Related]
3. Serological biomarkers in hemophilic arthropathy: Can they be used to monitor bleeding and ongoing progression of blood-induced joint disease in patients with hemophilia?
Rodriguez-Merchan EC
Blood Rev; 2020 May; 41():100642. PubMed ID: 31796337
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of hemophilic arthropathy and potential targets for therapy.
Pulles AE; Mastbergen SC; Schutgens RE; Lafeber FP; van Vulpen LF
Pharmacol Res; 2017 Jan; 115():192-199. PubMed ID: 27890816
[TBL] [Abstract][Full Text] [Related]
5. The F8(-/-) rat as a model of hemophilic arthropathy.
Sørensen KR; Roepstorff K; Wiinberg B; Hansen AK; Tranholm M; Nielsen LN; Kjelgaard-Hansen M
J Thromb Haemost; 2016 Jun; 14(6):1216-25. PubMed ID: 27060449
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell-derived factor 1 alpha (SDF-1alfa) and cartilage oligomeric matrix protein (COMP): Two potential signature biomarkers of radiological detectable hemophilic arthropathy.
Leuci A; Robert M; Josset L; Marano M; Connes P; Désage S; Meunier S; Lienhart A; Dargaud Y
Int J Rheum Dis; 2024 Feb; 27(2):e15061. PubMed ID: 38465833
[TBL] [Abstract][Full Text] [Related]
7. Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A.
Melchiorre D; Linari S; Manetti M; Romano E; Sofi F; Matucci-Cerinic M; Carulli C; Innocenti M; Ibba-Manneschi L; Castaman G
Haematologica; 2016 Feb; 101(2):219-25. PubMed ID: 26494839
[TBL] [Abstract][Full Text] [Related]
8. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
Jansen NW; Roosendaal G; Lundin B; Heijnen L; Mauser-Bunschoten E; Bijlsma JW; Theobald M; Lafeber FP
Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
[TBL] [Abstract][Full Text] [Related]
9. The early bone and joint changes in haemophilia and similar blood dyscrasias.
Boldero JL; Kemp HS
Br J Radiol; 1966 Mar; 39(459):172-80. PubMed ID: 5930807
[No Abstract] [Full Text] [Related]
10. Blood-induced joint damage in hemophilia.
Roosendaal G; Lafeber FP
Semin Thromb Hemost; 2003 Feb; 29(1):37-42. PubMed ID: 12640563
[TBL] [Abstract][Full Text] [Related]
11. The role of six biomarkers in diagnosis of hemophilic arthropathy: review of the literature.
Pasta G; Jannelli E; Ivone A; Mosconi M; Ferranti Calderoni E; Minen A; Benazzo F; Rodriguez-Merchan EC
J Biol Regul Homeost Agents; 2020; 34(3 Suppl. 2):7-13. ADVANCES IN MUSCULOSKELETAL DISEASES AND INFECTIONS - SOTIMI 2019. PubMed ID: 32856434
[TBL] [Abstract][Full Text] [Related]
12. The phenotypic heterogeneity of severe hemophilia.
Jayandharan GR; Srivastava A
Semin Thromb Hemost; 2008 Feb; 34(1):128-41. PubMed ID: 18393149
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of the disturbed angiogenesis in hemophilia.
Rodriguez-Merchan EC
Expert Rev Hematol; 2016 Oct; 9(10):933-8. PubMed ID: 27624637
[TBL] [Abstract][Full Text] [Related]
14. What is the Effect of Bevacizumab on Cartilage and Synovium in a Rabbit Model of Hemophilic Arthropathy?
Mert L; Bilgiç B; Şenol BK; Zülfikar OB; Durmaz H; Polat G
Clin Orthop Relat Res; 2023 Aug; 481(8):1634-1647. PubMed ID: 37036937
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Vascular remodeling underlies rebleeding in hemophilic arthropathy.
Bhat V; Olmer M; Joshi S; Durden DL; Cramer TJ; Barnes RF; Ball ST; Hughes TH; Silva M; Luck JV; Moore RE; Mosnier LO; von Drygalski A
Am J Hematol; 2015 Nov; 90(11):1027-35. PubMed ID: 26257191
[TBL] [Abstract][Full Text] [Related]
17. The management of musculoskeletal problems in hemophilia. Part II. Pathophysiologic and roentgenographic changes in hemophilic arthropathy.
Greene WB; Wilson FC
Instr Course Lect; 1983; 32():217-23. PubMed ID: 6546070
[No Abstract] [Full Text] [Related]
18. [Pathology of synovitis and hemophilic arthropathy].
Roosendaal G; van den Berg HM; Lafeber FP; Bijlsma J
Orthopade; 1999 Apr; 28(4):323-8. PubMed ID: 10335526
[TBL] [Abstract][Full Text] [Related]
19. Advances and challenges in hemophilic arthropathy.
Wyseure T; Mosnier LO; von Drygalski A
Semin Hematol; 2016 Jan; 53(1):10-9. PubMed ID: 26805902
[TBL] [Abstract][Full Text] [Related]
20. Hemophilic arthropathy of the elbow.
Adams JE; Reding MT
Hand Clin; 2011 May; 27(2):151-63, v. PubMed ID: 21501786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
